Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Frontiers in Neurology|August 17, 2019
Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of MedicationIgor Straka, Michal Minár, Matej Škorvánek, et al.International Journal of Molecular Sciences|February 15, 2022
Alzheimer's Disease-Associated SNP rs708727 in SLC41A1 May Increase Risk for Parkinson's Disease: Report from Enlarged Slovak StudyMichal Cibulka, Maria Brodnanova, Marian Grendar, et al.Neurologia I Neurochirurgia Polska|November 20, 2024
Acute polyneuropathy: a serious complication of levodopa/ /carbidopa intestinal gel treatment for Parkinson's DiseasePetra Havránková, Jan Roth, Václav Čapek, et al.Research Square|June 10, 2024
p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central EuropeMiriam Ostrozovicova, Gertrud Tamas, Petr Dušek, et al.Movement Disorders Clinical Practice|March 22, 2025
Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early-Onset and Familial Parkinson's DiseaseMiriam Ostrozovicova, Gertrud Tamas, Agsha Atputhavadivel, et al.Parkinsonism & Related Disorders|April 8, 2018
Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patientsMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.Movement Disorders Clinical Practice|October 27, 2018
Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease DurationMatej Skorvanek, Pablo Martinez-Martin, Norbert Kovacs, et al.Pageof 3